文献速递胃肠外科

胃癌术后晚期并发症:JCOG0912补充分析

Late complication after gastrectomy for clinical stage I cancer: supplementary analysis of JCOG0912.
PubMed 文献 · Surg Endosc · 2022-12-13

基于JCOG0912试验881例临床I期胃癌患者,比较腹腔镜与开腹远端胃切除术后晚期并发症。手术入路与晚期并发症类型或数量无关,Billroth-I重建降低胆囊炎和肠梗阻风险,保留幽门胃切除增加反流性食管炎风险。

要点

  • 腹腔镜与开腹远端胃切除术的晚期并发症类型及数量无差异。
  • Billroth-I重建较R-en-Y或Billroth-II降低胆囊炎和肠梗阻风险。
  • 保留幽门胃切除较R-en-Y或Billroth-II增加反流性食管炎风险。

核心结论

  • 手术入路不是胃癌术后晚期并发症的危险因素。
  • Billroth-I重建降低肠梗阻和胆囊炎风险,保留幽门胃切除增加反流性食管炎风险。

研究设计与样本

  • JCOG0912试验的补充分析,纳入881/921例临床I期胃癌患者,比较腹腔镜辅助与开腹远端胃切除术。

主要发现

  • 腹腔镜与开腹组的晚期并发症类型或患者数量无差异。
  • Billroth-I重建与R-en-Y或Billroth-II相比,胆囊炎风险OR 0.187(95%CI 0.039-0.905,P=0.037),肠梗阻风险OR 0.116(95%CI 0.033-0.406,P<0.001)。
  • 保留幽门胃切除与R-en-Y或Billroth-II相比,反流性食管炎风险OR 3.348(95%CI 1.371-8.176,P=0.008)。

关键数值与推荐

  • Billroth-I重建降低胆囊炎风险:OR 0.187(95%CI 0.039-0.905,P=0.037)。
  • Billroth-I重建降低肠梗阻风险:OR 0.116(95%CI 0.033-0.406,P<0.001)。
  • 保留幽门胃切除增加反流性食管炎风险:OR 3.348(95%CI 1.371-8.176,P=0.008)。

临床怎么用

  • 选择Billroth-I重建可能减少术后胆囊炎和肠梗阻。
  • 采用保留幽门胃切除时需关注反流性食管炎风险。
  • 手术入路选择不影响晚期并发症发生。

局限性

  • 本研究为JCOG0912试验的补充分析,非预设分析。
  • 仅纳入临床I期胃癌患者,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Late complications following gastric cancer surgery, including postgastrectomy syndromes, are complex problems requiring a solution. Reported risk factors for developing late complications include surgery-related factors, such as the surgical approach and the extent of resection and reconstruction. However, this has not been assessed in a prospective study with a large sample size. Therefore, this study aimed to evaluate associations between surgery-related factors and the development of late complications. Data from the JCOG0912 trial were used. It compared laparoscopy-assisted distal gastrectomy (LADG) to open distal gastrectomy (ODG) in clinical stage I gastric cancer patients. METHODS: This study included 881/921 patients enrolled in the JCOG0912 trial. The incidence of late complications was compared between the ODG and the LADG arms. In addition, associations between surgery-related factors and the development of late complications were assessed by multivariable analyses using the proportional odds model to identify relevant risk factors. RESULTS: There was no difference in the type or number of patients with late complications between the LADG and the ODG arms. The multivariable analysis for each late complication revealed that the Billroth-I reconstruction (vs. R-en-Y or Billroth-II) had a lower risk of cholecystitis [odds ratio (OR) 0.187, 95% confidence interval (CI) 0.039-0.905, P = 0.037] or ileus (OR 0.116, 95%CI 0.033-0.406, P < 0.001), and pylorus-preserving gastrectomy (vs. R-en-Y or Billroth-II) had a higher risk of reflux esophagitis (OR 3.348, 95% CI 1.371-8.176, P = 0.008). The surgical approach was not a risk factor for any late complications. CONCLUSION: Differences in surgical approaches did not constitute a risk for developing late complications after gastrectomy. Billroth-I reconstruction reduced the risk of ileus and cholecystitis, but pylorus-preserving gastrectomy carried a risk for reflux esophagitis.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Hikage M, Hato S, Uemura K, et al. Late complication after gastrectomy for clinical stage I cancer: supplementary analysis of JCOG0912. Surg Endosc. 2022. PMID: 36512122. doi:10.1007/s00464-022-09804-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。